Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | PNLIP | P16233 | 2/20 | 0.41 |
| ▸ | FAAH | O00519 | 5/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CNR1 | P21554 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | MMP2 | P08253 | 2/20 | 0.39 |
| ▸ | MMP9 | P14780 | 2/20 | 0.39 |
| ▸ | MMP12 | P39900 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6865657 | 0.99 | ALDH1A1 (0.53) | ALDH1A1TSHRPNLIPFAAHL3MBTL1 | |
| SCHEMBL6864942 | 0.89 | ALDH1A1 (0.53) | ALDH1A1TSHRFAAHL3MBTL1KDM4E | |
| SCHEMBL28344298 | 0.87 | ALDH1A1 (0.52) | ALDH1A1TSHRFAAHL3MBTL1KDM4E | |
| SCHEMBL6864250 | 0.87 | ALDH1A1 (0.56) | ALDH1A1TSHRPNLIPFAAHL3MBTL1 | |
| SCHEMBL1704751 | 0.87 | ALDH1A1 (0.64) | ALDH1A1TSHRPNLIPFAAHL3MBTL1 | |
| SCHEMBL7175934 | 0.84 | ALDH1A1 (0.57) | ALDH1A1TSHRFAAHL3MBTL1KDM4E | |
| SCHEMBL7171711 | 0.84 | ALDH1A1 (0.57) | ALDH1A1TSHRFAAHL3MBTL1KDM4E | |
| SCHEMBL7870401 | 0.83 | TSHR (0.56) | ALDH1A1TSHRFAAHL3MBTL1MAPT | |
| SCHEMBL6390359 | 0.82 | CA12 (0.57) | ALDH1A1TSHRPNLIPFAAH | |
| SCHEMBL9493320 | 0.82 | ALDH1A1 (0.59) | ALDH1A1TSHRFAAHL3MBTL1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6805921-B2 | Liquid crystal display | MITSUBISHI GAS CHEMICAL CO., INC. (JP) | 2004-10-19 | — | — | US | disclosed |
| US-20030102459-A1 | Optically active compound and nematic liquid crystal composition containing the compound | MITSUBISHI GAS CHEMICAL CO., INC. | 2003-06-05 | — | — | US | disclosed |
| EP-1283253-A1 | Optically active compound and nematic liquid crystal composition containing the compound | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2003-02-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030102459-A1 | Optically active compound and nematic liquid crystal composition containing the compound | NCAPH, H1-0, CNOT1 | ALDH1A1 3895/4885TSHR 4320/4885PNLIP 4079/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.